Alps Advisors Inc. lifted its stake in Exponent, Inc. (NASDAQ:EXPO - Free Report) by 7.7% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 73,182 shares of the business services provider's stock after acquiring an additional 5,246 shares during the quarter. Alps Advisors Inc. owned 0.14% of Exponent worth $5,932,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors have also recently made changes to their positions in EXPO. Norges Bank bought a new stake in Exponent during the fourth quarter valued at approximately $52,381,000. Resona Asset Management Co. Ltd. bought a new stake in Exponent during the fourth quarter valued at approximately $38,538,000. BLI Banque de Luxembourg Investments bought a new stake in Exponent during the fourth quarter valued at approximately $12,564,000. Barclays PLC grew its position in Exponent by 88.5% during the fourth quarter. Barclays PLC now owns 181,921 shares of the business services provider's stock valued at $16,209,000 after buying an additional 85,395 shares during the period. Finally, Arrowstreet Capital Limited Partnership grew its position in Exponent by 1,061.1% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 85,790 shares of the business services provider's stock valued at $7,644,000 after buying an additional 78,401 shares during the period. 92.37% of the stock is currently owned by institutional investors.
Insider Activity at Exponent
In related news, VP Bradley A. James sold 2,694 shares of Exponent stock in a transaction on Tuesday, May 20th. The shares were sold at an average price of $79.52, for a total transaction of $214,226.88. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, VP John Pye sold 2,000 shares of Exponent stock in a transaction on Friday, May 23rd. The shares were sold at an average price of $76.32, for a total transaction of $152,640.00. Following the transaction, the vice president owned 29,204 shares in the company, valued at approximately $2,228,849.28. This trade represents a 6.41% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 6,267 shares of company stock worth $489,120. 1.60% of the stock is owned by corporate insiders.
Exponent Trading Up 0.2%
NASDAQ EXPO traded up $0.14 during trading hours on Monday, hitting $74.46. 206,963 shares of the company's stock traded hands, compared to its average volume of 310,266. The business's fifty day moving average price is $76.52 and its two-hundred day moving average price is $82.01. The firm has a market capitalization of $3.78 billion, a P/E ratio of 36.32 and a beta of 0.90. Exponent, Inc. has a 52 week low of $72.43 and a 52 week high of $115.75.
Exponent (NASDAQ:EXPO - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The business services provider reported $0.52 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.48 by $0.04. Exponent had a net margin of 18.87% and a return on equity of 25.33%. The firm had revenue of $137.44 million during the quarter, compared to analysts' expectations of $134.63 million. During the same period in the prior year, the company posted $0.59 earnings per share. The company's revenue for the quarter was up .2% compared to the same quarter last year. On average, sell-side analysts expect that Exponent, Inc. will post 1.98 EPS for the current fiscal year.
Exponent Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, June 20th. Investors of record on Friday, June 6th were paid a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.61%. The ex-dividend date of this dividend was Friday, June 6th. Exponent's dividend payout ratio (DPR) is 58.54%.
Exponent Company Profile
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Recommended Stories

Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.